Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

BetterLife Announces Debt Settlements
Posted On Tuesday, May 06, 2025
Senti Bio Reports First Quarter 2025 Financial Results and Provides a Corporate Update on Positive SENTI-202 Clinical Development
Posted On Tuesday, May 06, 2025
Cellectis to Report First Quarter Financial Results on May 12, 2025
Posted On Tuesday, May 06, 2025
MacroGenics Announces Date of First Quarter 2025 Financial Results
Posted On Tuesday, May 06, 2025
Leading Independent Proxy Advisory Firm ISS Recommends ACELYRIN Stockholders Vote “FOR” the Proposed Transaction with Alumis
Posted On Tuesday, May 06, 2025
Lexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference
Posted On Tuesday, May 06, 2025
BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates
Posted On Tuesday, May 06, 2025
Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates
Posted On Tuesday, May 06, 2025
Supernus Announces First Quarter 2025 Financial Results
Posted On Tuesday, May 06, 2025
BioAtla Reports First Quarter 2025 Financial Results and Highlights Recent Progress
Posted On Tuesday, May 06, 2025
Myriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance
Posted On Tuesday, May 06, 2025
Prelude Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
Posted On Tuesday, May 06, 2025
89bio to Participate in Upcoming Investor Conferences
Posted On Tuesday, May 06, 2025
Day One Reports First Quarter 2025 Financial Results and Corporate Progress
Posted On Tuesday, May 06, 2025
Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome
Posted On Tuesday, May 06, 2025
Keros Therapeutics Reports Recent First Quarter 2025 Financial Results
Posted On Tuesday, May 06, 2025
Voyager Reports First Quarter 2025 Financial and Operating Results
Posted On Tuesday, May 06, 2025
Arcutis Announces First Quarter 2025 Financial Results and Provides Business Update
Posted On Tuesday, May 06, 2025
Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
Posted On Tuesday, May 06, 2025
Cytokinetics Reports First Quarter 2025 Financial Results and Provides Business Update
Posted On Tuesday, May 06, 2025
Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq
Posted On Tuesday, May 06, 2025
Keiretsu Forum Mid-Atlantic and South-East Appoints Christian Haller as Regional Vice President, Signaling Strategic Leadership Expansion
Posted On Tuesday, May 06, 2025
Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs
Posted On Tuesday, May 06, 2025
Sitryx nominates SIT-047, a novel, oral MTHFD2 inhibitor, for clinical development in psoriatic arthritis
Posted On Tuesday, May 06, 2025
Essential Pharma strengthens management team with appointment of Duncan Ferguson as Vice President, Commercial
Posted On Tuesday, May 06, 2025

Print